Evidence map›Paper›PMID 41969638›Full record

ReviewOne health (Amsterdam, Netherlands)2026

MediLabSecure: A decade of One Health actions to prevent emerging vector-borne diseases in the Mediterranean, Sahel and Black Sea regions.

Vanessa Lagal, Elisa Pérez-Ramírez, Guillain Mikaty, Laura Amato, Claudia Robbiati, Igor Pajovic, Nebojsa Sekulic, Aleksandra Ignjatović Ćupina, Mihaela Kavran, Nabil Haddad and 15 more

Abstract readReview
In one paragraph

Review in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Vanessa LagalInstitut Pasteur, Université Paris Cité, Department of International Affairs, Paris, France.
Elisa Pérez-RamírezCentro de Investigación en Sanidad Animal (CISA-INIA), CSIC, Valdeolmos 28130, Madrid, Spain.
Guillain MikatyInstitut Pasteur, Université Paris Cité, Environment and Infectious Risk Research Unit - Laboratory for Urgent Response to Biological Threats (ERI-CIBU), Paris, France.
Laura AmatoCentro di Referenza Nazionale per l'Epidemiologia Veterinaria, la Programmazione, l'Informazione e l'Analisi del Rischio Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.
Claudia RobbiatiNational Centre for Global Health, Istituto Superiore di Sanità, Rome, Italy.
Igor PajovicLaboratory for Applied Zoology, Biotechnical Faculty, University of Montenegro, Podgorica, Montenegro.
Nebojsa SekulicCenter for Control and prevention of infectious diseases, Institute of Public Health of Montenegro, Podgorica, Montenegro.
Aleksandra Ignjatović ĆupinaUniversity of Novi Sad, Faculty of Agriculture, Center of Excellence-One Health Vectors and Climate, Novi Sad, Serbia.
Mihaela KavranUniversity of Novi Sad, Faculty of Agriculture, Center of Excellence-One Health Vectors and Climate, Novi Sad, Serbia.
Nabil HaddadLaboratory of Immunology and Vector-Borne Diseases, Faculty of Public Health, Lebanese University, Fanar, Lebanon.
Rita FeghaliDepartment of Laboratory Medicine, Lebanese American University Gilbert and Rose Marie Chagoury School of Medicine, Blat, Lebanon.
Sylvia KaramDepartment of Laboratory Medicine, Rafik Hariri University Hospital, Beirut, Lebanon.
Wasfi FaresClinical virology laboratory, Institut Pasteur de Tunis, Tunis, Tunisia.
Henda TrikiClinical virology laboratory, Institut Pasteur de Tunis, Tunis, Tunisia.
Maud SeguyInstitut Pasteur, Université Paris Cité, Department of International Affairs, Paris, France.
Jovita Fernández-PineroCentro de Investigación en Sanidad Animal (CISA-INIA), CSIC, Valdeolmos 28130, Madrid, Spain.
Pilar Aguilera-SepúlvedaCentro de Investigación en Sanidad Animal (CISA-INIA), CSIC, Valdeolmos 28130, Madrid, Spain.
Silvia DeclichNational Centre for Global Health, Istituto Superiore di Sanità, Rome, Italy.
Cedric MarsboomResearch Department, Avia-GIS, Zoersel, Belgium.
Miguel Angel Jiménez-ClaveroCentro de Investigación en Sanidad Animal (CISA-INIA), CSIC, Valdeolmos 28130, Madrid, Spain.
Florence FournetMIVEGEC Unit, Université de Montpellier, Institut de Recherche pour le Développement (IRD), Centre National de Recherche Scientifique (CNRS), Montpellier, France.
Paolo CalistriCentro di Referenza Nazionale per l'Epidemiologia Veterinaria, la Programmazione, l'Informazione e l'Analisi del Rischio Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.
Guy HendrickxResearch Department, Avia-GIS, Zoersel, Belgium.
Maria Grazia DenteNational Centre for Global Health, Istituto Superiore di Sanità, Rome, Italy.
Jean-Claude ManuguerraInstitut Pasteur, Université Paris Cité, Environment and Infectious Risk Research Unit - Laboratory for Urgent Response to Biological Threats (ERI-CIBU), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising incidence of vector-borne diseases driven by environmental degradation and climate change poses significant risks for human health. The implementation of integrated surveillance systems is of paramount importance to efficiently mitigate their emergence and spread. MediLabSecure (MLS) is a pioneer One Health network launched by the European Union in 2014 to strengthen preparedness and response capacities to tackle vector-borne diseases (VBD) in the Mediterranean, Black Sea and Sahel regions, which are known hotspots for endemic and emerging vector-borne pathogens. MLS unites experts from human health, animal health and entomology across 24 countries to foster cross-sectoral collaboration through capacity building, networking, and regional cooperation. By promoting the development and implementation of integrated surveillance systems, MLS facilitates coordinated pathogen detection, vector monitoring, risk assessment, and control strategies that encompass the human-animal-environment interface. Over its ten-year history, the network has substantially strengthened technical capacities enabling improved arbovirus detection in human and animal samples, vector identification mapping and control, and integrated surveillance and risk assessment. The network experience demonstrates the critical importance of coordinated multisectoral actions, regional partnerships, and long-term investments in capacity building to combat existing and future health threats at the human-animal-environment interface. The bottom-up approach of the project, tailored to the specific needs of the beneficiary countries along with its long-term implementation - which fostered trust and stable collaborative initiatives - were key factors contributing to the success of MLS. This unique project offers a valuable blueprint for other regions aiming to implement One Health strategies to address complex transboundary public health challenges.

Indexed as

Capacity buildingIntegrated surveillanceOne HealthPreparednessRegional networkVector-borne diseasesZoonoses

Identifiers

PMID41969638
PMCPMC13068619

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.